Min Kwan-Hong Christopher 4/A

4/A · Longeveron Inc. · Filed Apr 12, 2022

Form 4/AAmended

Period: 2022-04-04

Chief Medical Officer

Transactions

Award
Common Stock
2022-04-04+2,335→ 2,335 total
Award
Stock Option (right to buy)
2022-04-04+2,335→ 2,335 total
Exercise: $12.85Exp: 2032-04-03→ Common Stock (2,335 underlying)
Award
Stock Option (right to buy)
2022-04-04+150,000→ 50,000 total
Exercise: $12.85Exp: 2032-04-03→ Common Stock (50,000 underlying)
Tax Payment
Common Stock
2022-04-04−357→ 1,978 total
Award
Common Stock
2022-04-04+150,000→ 151,978 total

Footnotes (7)

[F1]Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
[F2]Includes 2,335 Restricted Stock Units.
[F3]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022.
[F4]Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.
[F5]Includes 151,978 Restricted Stock Units.
[F6]The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
[F7]The option vests ratably 25% each year.

Documents

1 file